J&J to enter the robotic surgery market with $3.4B Auris Health buy

J&J to enter the robotic surgery market with $3.4B Auris Health buy

Source: 
Mass Device
snippet: 

Johnson & Johnson (NYSE:JNJ) will be stepping into the field of robotic surgery after saying today that its Ethicon subsidiary inked a $3.4 billion deal to pick up surgical robotics pioneer Dr. Fred Moll’s newest robotic surgical play, Auris Health, and its FDA-cleared Monarch platform.